Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small ...
The automation-compatible, bead-based method optimizes cfDNA recovery from plasma, serum, urine and cerebrospinal fluidIPSWICH, Mass., Feb. 12, 2026 ...
Suicide rates among Black youth have risen sharply in recent years, surpassing those of other racial and ethnic groups. In 2023, it was the third ...
China infrastructure advantage remains central to Asian manufacturing competitiveness, shaping efficiency and resilience.
Distance, lack of coverage, and mistrust have limited Indigenous patients' access to basic and advanced medicine, but cancer centers are embracing strategies to change that.
Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...
The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and ...
The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and projected to reach US$3.7 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results